about
Natural Killer Receptor 1 Dampens the Development of Allergic Eosinophilic Airway InflammationNKp44 Receptor Mediates Interaction of the Envelope Glycoproteins from the West Nile and Dengue Viruses with NK CellsCharacterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46NKp46 Clusters at the Immune Synapse and Regulates NK Cell Polarization.Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.CD100 on NK cells enhance IFNgamma secretion and killing of target cells expressing CD72Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences.Dual fluorescent labelling of the human malaria parasite Plasmodium falciparum for the analysis of the ABC type transporter pfmdr2.NADH oxidase functions as an adhesin in Streptococcus pneumoniae and elicits a protective immune response in mice.An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificities.Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes.Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue.A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.A novel "reactomics" approach for cancer diagnosticsExtracting tumor tissue immune status from expression profiles: correlating renal cancer prognosis with tumor-associated immunome.Cell type-specific DNA methylation patterns in the human breastGenome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.Survival in acute myeloid leukemia is associated with NKp44 splice variants.Novel APC-like properties of human NK cells directly regulate T cell activationNKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpointRegulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant ExpressionThe effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands.Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surfaceExpression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRIActivating NK cell receptor ligands are differentially expressed during progression to cervical cancer.Expression of ligands to NKp46 in benign and malignant melanocytes.Upregulation of MHC class I expression following dengue virus infection: the mechanism at the promoter level.Chimeric vaccine composed of viral peptide and mammalian heat-shock protein 60 peptide protects against West Nile virus challenge.Tumor vaccination by Salmonella typhimurium after transformation with a eukaryotic expression vector in mice: impact of a Salmonella typhimurium gene interfering with MHC class I presentation.Streptococcus pneumoniae fructose-1,6-bisphosphate aldolase, a protein vaccine candidate, elicits Th1/Th2/Th17-type cytokine responses in mice.Correction: harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.The activating receptor NKp46 is essential for the development of type 1 diabetes.Array-based disease diagnostics using lipid/polydiacetylene vesicles encapsulated in a sol-gel matrix.Detection of Reactive Oxygen Species by a Carbon-Dot-Ascorbic Acid Hydrogel.Colorimetric polymer assay for the diagnosis of plasma lipids atherogenic quality in hypercholesterolemic patients.Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor.
P50
Q27330062-AD120C8C-9EA7-419F-AEB4-BE516CF48C7DQ27490238-30EDF50A-3986-4404-9EF1-799404A8BDBDQ28279817-4A0E9AA7-63AB-4DEC-A1E0-919677FCC108Q30665729-7C606488-DA5B-4CBF-9A31-1A51A31BF299Q33292532-0DB05E2B-B419-4A06-AF14-A459FDAAB4EBQ33296978-ECEDE5C3-0A02-40D2-8580-829B3E8C0CCBQ33334362-2267D855-284C-4311-837A-AD5AD436A0F8Q33405958-84B11B87-AF5F-482D-AF95-60F7DCD05A12Q34471140-A6B63FE3-263B-4C97-9A39-DB496A52F0A1Q34664119-76E90E2E-2E53-4B01-9D17-8CD4422331B9Q34786615-38C40828-1F11-47B6-BC5F-6D8764CAAC08Q35125149-B6F1FF34-9306-4659-A432-41AA6DA9DE1DQ35556765-C82354BE-AA1E-491D-B6FE-842F76964288Q35669969-7BBA455C-3B79-4D55-A55C-E3F87E993FB6Q36057472-59D7475B-D51F-41FB-B9DB-C405D0574CB4Q36067925-73091A71-92EF-4532-98C7-0F9A825B0C7DQ36545108-235BD49A-5B24-4DB7-AA63-A3A3763FB07AQ36869180-ADD10821-A078-4269-81FD-2C4BBB1C64E2Q37332652-C6DB297D-556B-43D9-A09A-F654972C0066Q37362807-9F334976-FF4B-47C1-8791-E2F0D4944CF9Q37625916-DD6B1B2B-EBE5-46F4-8A91-05F842183900Q37688634-5AD5512C-55C0-456E-AE9D-85EA5D824908Q37727470-1F17A76D-8184-42BC-B43C-7AF07A389ED3Q37993185-5BE543E4-1870-4A76-89A5-EB3C993C295BQ38004630-30FEFEC5-4E7F-4CED-BFDF-2D3D52E8B9BBQ38235405-E467C53C-C8E2-4298-B478-516E81575997Q38713604-A5F4FF8C-733F-4D20-B685-54D471A757E6Q38848145-D7995DA7-5D33-4AEF-B43A-4D4D99D6CB8FQ39949375-38FF599B-64FA-48A8-B865-27A0904D10CFQ40059638-981E4039-7127-4B95-A34C-698F498F381EQ40293988-CC14DF7F-32B4-4894-ACB2-95A6C40FECDFQ40363195-80F75B21-A9B1-461C-B054-B24E28F809C8Q40382860-613A069D-7CC1-4962-9CF3-5330671F0C14Q40770018-2A1782FC-6836-4FCC-87AB-D5E158752BF7Q42575521-9967319C-29AC-4598-A4F8-E47500FA6A9BQ43214288-A06A3F11-131E-4EB2-8789-02F83187FBF5Q45960455-B8209DC2-B41A-4E34-9800-B3CA248DFCD4Q46443572-D4A9E2D7-90A5-411A-BB5A-AAC2E6BD4997Q46772985-BF682C46-BD70-4B31-B4BC-5EBC6CE561E3Q47111488-D6EDFEA8-BA98-4308-B937-B527CDD8ABCB
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Angel Porgador
@en
Angel Porgador
@nl
type
label
Angel Porgador
@en
Angel Porgador
@nl
prefLabel
Angel Porgador
@en
Angel Porgador
@nl
P31
P496
0000-0003-1540-4449